Gene Expression of WWOX, FHIT and P73 in Acute Lymphoblastic Leukemia

Overview

Journal Oncol Lett

Specialty Oncology

Date 2013 Oct 19

PMID 24137446

Citations 15

Authors

Xu Chen

Hui Zhang

Ping Li

Zheng Yang

Lingyan Qin

Wuning Mo

Affiliations

Soon will be listed here.

Abstract

The aim of the present study was to analyze the expression of WW-domain oxidoreductase (WWOX), fragile histidine triad (FHIT) and p73 in acute lymphoblastic leukemia (ALL). Samples from 122 ALL patients and 35 non-ALL control patients were collected in this study. RT-PCR was performed to detect the mRNA expression of WWOX, FHIT and p73. The methylation status of the WWOX promoter region, FHIT promoter region and the first exon region of p73 were also analyzed using the methylation-specific PCR method. The mRNA expression of WWOX, FHIT and p73 was significantly lower in the ALL samples compared with the controls (48.2, 42.9 and 55.4%, respectively). By contrast, the methylation frequency of WWOX, FHIT and p73 was significantly higher in the ALL samples compared with the controls (44.6, 46.4 and 37.5%, respectively). The mRNA expression of these three genes was inversely correlated with the methylation frequency in the ALL samples (correlation coefficients, -0.661, -0.685 and -0.536 for WWOX, FHIT and p73, respectively). Moreover, the mRNA expression of WWOX was positively correlated with that of FHIT and p73 (correlation coefficients, 0.569 and 0.556, respectively). However, the methylation status of WWOX had no correlation with that of FHIT or p73. It was concluded that the high methylation status of WWOX, FHIT and p73 may lead to the inactivation of expression and the silencing of these genes, promoting the occurrence and development of ALL. The determination of the mRNA expression and methylation status of WWOX, FHIT and p73 may aid in the development of treatment approaches for ALL.

Citing Articles

The relationship between expression level and gene polymorphism of inflammatory factors and sepsis risk.

Wang S, Liang T, Zhang C Sci Rep. 2025; 15(1):6701.

PMID: 40000789 PMC: 11861965. DOI: 10.1038/s41598-025-90995-0.

Genetic polymorphism of IL-18 influences susceptibility to lung cancer in population of eastern China.

Chen X, Yao Y, Lao J, Li H, Fu H, Qiu J J Cancer. 2024; 15(14):4604-4611.

PMID: 39006070 PMC: 11242331. DOI: 10.7150/jca.97039.

Tumor necrosis factor-α polymorphism and risk of primary nephrotic syndrome: A case-control study and meta-analysis.

Zhao R, Wang Y, Zhou Y, Fan W, Yin H Immun Inflamm Dis. 2024; 12(6):e1278.

PMID: 38860750 PMC: 11165685. DOI: 10.1002/iid3.1278.

MMP-3 gene regulates the carcinogenesis and metabolic process of ovarian cancer, evidence from a Chinese population: Observational study and meta-analysis.

Wang L, Yao Y, Si D Medicine (Baltimore). 2023; 102(50):e36471.

PMID: 38115289 PMC: 10727570. DOI: 10.1097/MD.0000000000036471.

Genetic Polymorphism of Lipoprotein-Associated Phospholipase A2 Influences Susceptibility to Gestational Diabetes Mellitus in Chinese Population.

Qin L, Ma Q, Zhang C, Lu Z, Liu L, Huang Z Diabetes Metab Syndr Obes. 2023; 16:3285-3294.

PMID: 37881351 PMC: 10595992. DOI: 10.2147/DMSO.S430352.

References

Ohta M, Inoue H, Cotticelli M, Kastury K, Baffa R, Palazzo J . The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell. 1996; 84(4):587-97. DOI: 10.1016/s0092-8674(00)81034-x. View

Iwai M, Kiyoi H, Ozeki K, Kinoshita T, Emi N, Ohno R . Expression and methylation status of the FHIT gene in acute myeloid leukemia and myelodysplastic syndrome. Leukemia. 2005; 19(8):1367-75. DOI: 10.1038/sj.leu.2403805. View

Aqeilan R, Croce C . WWOX in biological control and tumorigenesis. J Cell Physiol. 2007; 212(2):307-10. DOI: 10.1002/jcp.21099. View

Roman-Gomez J, Jimenez-Velasco A, Castillejo J, Agirre X, Barrios M, Navarro G . Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemia. Blood. 2004; 104(8):2492-8. DOI: 10.1182/blood-2004-03-0954. View

Iwai T, Yokota S, Nakao M, Nakazawa N, Taniwaki M, Kimura T . Frequent aberration of FHIT gene expression in acute leukemias. Cancer Res. 1998; 58(22):5182-7. View

Tseng J, Kemp B, Khuri F, Kurie J, Lee J, Zhou X . Loss of Fhit is frequent in stage I non-small cell lung cancer and in the lungs of chronic smokers. Cancer Res. 1999; 59(19):4798-803. View

Nunez M, Ludes-Meyers J, Abba M, Kil H, Abbey N, Page R . Frequent loss of WWOX expression in breast cancer: correlation with estrogen receptor status. Breast Cancer Res Treat. 2005; 89(2):99-105. PMC: 4145848. DOI: 10.1007/s10549-004-1474-x. View

Maeda N, Semba S, Nakayama S, Yanagihara K, Yokozaki H . Loss of WW domain-containing oxidoreductase expression in the progression and development of gastric carcinoma: clinical and histopathologic correlations. Virchows Arch. 2010; 457(4):423-32. DOI: 10.1007/s00428-010-0956-y. View

Pui C, Relling M, Downing J . Acute lymphoblastic leukemia. N Engl J Med. 2004; 350(15):1535-48. DOI: 10.1056/NEJMra023001. View

10.

Kosla K, Pluciennik E, Kurzyk A, Jesionek-Kupnicka D, Kordek R, Potemski P . Molecular analysis of WWOX expression correlation with proliferation and apoptosis in glioblastoma multiforme. J Neurooncol. 2010; 101(2):207-13. PMC: 2996532. DOI: 10.1007/s11060-010-0254-1. View

11.

Corn P, Kuerbitz S, van Noesel M, Esteller M, Compitello N, Baylin S . Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 5' CpG island methylation. Cancer Res. 1999; 59(14):3352-6. View

12.

Turner B, Ottey M, Zimonjic D, Potoczek M, Hauck W, Pequignot E . The fragile histidine triad/common chromosome fragile site 3B locus and repair-deficient cancers. Cancer Res. 2002; 62(14):4054-60. View

13.

Yang Y, Takeuchi S, Hofmann W, Ikezoe T, van Dongen J, Szczepanski T . Aberrant methylation in promoter-associated CpG islands of multiple genes in acute lymphoblastic leukemia. Leuk Res. 2005; 30(1):98-102. DOI: 10.1016/j.leukres.2005.06.002. View

14.

Redaelli A, Laskin B, Stephens J, Botteman M, Pashos C . A systematic literature review of the clinical and epidemiological burden of acute lymphoblastic leukaemia (ALL). Eur J Cancer Care (Engl). 2005; 14(1):53-62. DOI: 10.1111/j.1365-2354.2005.00513.x. View

15.

Alsop A, Taylor K, Zhang J, Gabra H, Paige A, Edwards P . Homozygous deletions may be markers of nearby heterozygous mutations: The complex deletion at FRA16D in the HCT116 colon cancer cell line removes exons of WWOX. Genes Chromosomes Cancer. 2008; 47(5):437-47. DOI: 10.1002/gcc.20548. View

16.

Connolly D, Greenspan D, Wu R, Ren X, Dunn R, Shah K . Loss of fhit expression in invasive cervical carcinomas and intraepithelial lesions associated with invasive disease. Clin Cancer Res. 2000; 6(9):3505-10. View

17.

Herman J, Graff J, Myohanen S, Nelkin B, Baylin S . Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A. 1996; 93(18):9821-6. PMC: 38513. DOI: 10.1073/pnas.93.18.9821. View

18.

Smith M, Seibel N, Altekruse S, Ries L, Melbert D, OLeary M . Outcomes for children and adolescents with cancer: challenges for the twenty-first century. J Clin Oncol. 2010; 28(15):2625-34. PMC: 2881732. DOI: 10.1200/JCO.2009.27.0421. View

19.

Campiglio M, Pekarsky Y, Menard S, Tagliabue E, Pilotti S, Croce C . FHIT loss of function in human primary breast cancer correlates with advanced stage of the disease. Cancer Res. 1999; 59(16):3866-9. View

20.

Hallas C, Albitar M, Letofsky J, Keating M, Huebner K, Croce C . Loss of FHIT expression in acute lymphoblastic leukemia. Clin Cancer Res. 1999; 5(9):2409-14. View